Pages that link to "Q24557553"

The following pages link to Focal hyperhidrosis: diagnosis and management (Q24557553):

Displaying 49 items.

• Distinguishing hyperhidrosis and normal physiological sweat production: new data and review of hyperhidrosis data for 1980-2013. (Q30884919) (← links)
• An epidemiological study of hyperhidrosis patients visiting the Ajou University Hospital hyperhidrosis center in Korea (Q33807283) (← links)
• A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis. (Q33933679) (← links)
• Management of hyperhidrosis (Q34446379) (← links)
• Retroperitoneoscopic lumbar sympathectomy for the treatment of plantar hyperhidrosis: technique and preliminary findings (Q34570687) (← links)
• The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study (Q34742931) (← links)
• Topical glycopyrrolate for patients with facial hyperhidrosis (Q34753953) (← links)
• Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial. (Q35557946) (← links)
• Non-cosmetic dermatological uses of botulinum neurotoxin (Q36078816) (← links)
• Comparison of microwave ablation, botulinum toxin injection, and liposuction-curettage in the treatment of axillary hyperhidrosis: A systematic review. (Q36174609) (← links)
• Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil (Q36243801) (← links)
• Treatment of primary axillary hyperhidrosis with botulinum toxin type a: our experience in 50 patients from 2007 to 2010 (Q36355396) (← links)
• Unlabeled uses of botulinum toxins: a review, part 1. (Q36359589) (← links)
• A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis (Q36554353) (← links)
• Temperament and character properties of primary focal hyperhidrosis patients (Q36630788) (← links)
• Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals (Q37076568) (← links)
• Hyperhidrosis--causes and treatment of enhanced sweating (Q37224719) (← links)
• Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis (Q37286003) (← links)
• Primary pediatric hyperhidrosis: a review of current treatment options (Q37344960) (← links)
• Hyperhidrosis: an update on prevalence and severity in the United States (Q37399262) (← links)
• Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects. (Q37540394) (← links)
• Use of botulinum toxin in the neurology clinic (Q37806619) (← links)
• Primary focal hyperhidrosis: current treatment options and a step‐by‐step approach (Q37900340) (← links)
• Systemic therapy for primary hyperhidrosis: A?retrospective study of 59 patients treated with glycopyrrolate or clonidine (Q37912443) (← links)
• A 69-year-old man with excessive sweating of the right hemithorax. (Q38018596) (← links)
• Update on pediatric hyperhidrosis (Q38189468) (← links)
• Treatment of Primary Craniofacial Hyperhidrosis: A Systematic Review (Q38521464) (← links)
• Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review (Q39038920) (← links)
• Incidence and frequency of endoscopic sympathectomy for the treatment of hyperhidrosis palmaris in Taiwan (Q39892072) (← links)
• Focal Hyperhidrosis Associated with Recurrent Urinary Tract Infections (Q40625163) (← links)
• Long-term outcomes after endothoracic sympathetic block at the T4 ganglion for upper limb hyperhidrosis (Q43410950) (← links)
• The evaluation of primary idiopathic focal hyperhidrosis patients in terms of alexithymia (Q44509028) (← links)
• New epidemiological aspects of patients with severe hyperhidrosis presenting for sympathetic surgery. (Q44582441) (← links)
• Botulinum toxin B in the treatment of craniofacial hyperhidrosis (Q45384356) (← links)
• Treatment of axillary hyperhidrosis/bromidrosis using VASER ultrasound (Q46175412) (← links)
• Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial (Q46638510) (← links)
• Quality of life after endoscopic lumbar sympathectomy for primary plantar hyperhidrosis (Q48057182) (← links)
• Subxiphoid single-incision thoracoscopic bilateral ablative sympathectomy for hyperhidrosis (Q48086990) (← links)
• Evaluation of topical liposome incorporated clove oil in the treatment of idiopathic palmar hyperhidrosis: Single-blinded placebo-controlled study. (Q48333218) (← links)
• Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival (Q48769192) (← links)
• [Hyperhidrosis of childhood and adolescence: clinical aspects and therapeutic options]. (Q52617210) (← links)
• Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis (Q56986357) (← links)
• (Q57215781) (← links)
• Endoscopic Lumbar Sympathectomy for Focal Plantar Hyperhidrosis Using the Clamping Method (Q84784410) (← links)
• Radiofrequency in the treatment of primary hyperhidrosis: systematic review and meta-analysis (Q90269315) (← links)
• Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use (Q90392746) (← links)
• A Case of Frey's Syndrome Diagnosed and Followed Up Using the Quantitative Sudomotor Axon Reflex Test (Q90579332) (← links)
• Hyperhidrosis Prevalence: A Disease Underreported by Patients and Underdiagnosed by Physicians (Q91741053) (← links)
• Reduction of focal sweating by lipid nanoparticle-delivered myricetin (Q98205081) (← links)